Newsletter | September 9, 2025
FEATURED EDITORIAL
Report: Nearly 40% Of Biomanufacturers Eyeing Continuous Processing
By Yasmin Timol, BioPlan Associates
Continuous perfusion manufacturing came about before the technology was mature enough to support it. Now, new data suggests an inflection point in the status quo.
MOST POPULAR NEWS
•
SeqOne Acquires Congenica To Create A Global Leader In AI-Powered Genomic Medicine
QIAGEN Gains U.S. Clearance Of Higher-Throughput QIAstat-Dx Rise
Arima Genomics Introduces Aventa Lymphoma Test To Resolve Diagnostic Uncertainty
3-Minute EEG Test Reliably Detects Memory Impairment
GeneseeqPrime® Gains FDA 510(k) Clearance
Golden Helix & Genomenon Announce Strategic Partnership To Advance Clinical Diagnostics
CARB-X Backs Neonatal Sepsis Diagnostic Platform By QuantaMatrix
Otsuka Pharmaceutical Diagnostic Division Opens A New Laboratory In Tokyo
GeodAIsics And HORIBA Partner To Develop AI-Powered Sepsis Detection Solution
MicroGenDX's New Testing Platform Cuts NGS Turnaround Time To 24 Hours
Mass General Brigham Launches Genetic Test Developed With Broad Clinical Labs
